ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,364.10
      -0.65%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Foghorn Therapeutics Inc (FHTX)

      7. Foghorn Therapeutics Inc (FHTX) Financials

      Foghorn Therapeutics Inc

      Foghorn Therapeutics Inc (FHTX)

      NASDAQ
      6.76
      0.24
      (3.68%)
      Closed July 28 4:00PM
      Delayed by 15 minutes
      6.76
      0.00
      (0.00%)
      After Hours: 6:41PM
      Delayed by 15 minutes

      Foghorn Therapeutics Inc Financial Summary

      The current FHTX market cap is 287.88M. The company's latest EPS is USD -2.3112 and P/E is -2.92.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 5.31M5.6M17.48M5.77M5.05M
      Operating Income -33.32M-32.05M-17.08M-30.78M-28.19M
      Net Income -30.49M-29.49M-14.35M-24.11M-25.02M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0430k1.32M19.23M34.16M
      Operating Income -51.08M-68.53M-100.73M-117.14M-107.91M
      Net Income -51.13M-68.8M-101.32M-108.88M-98.43M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 372.88M339.58M313.42M285.92M255M
      Total Liabilities 397.47M388.93M370.81M363.11M352.49M
      Total Equity -24.59M-49.35M-57.39M-77.19M-97.49M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 22.34M255.59M519.77M404.88M285.92M
      Total Liabilities 23.81M109.41M422.9M404.77M363.11M
      Total Equity -88.02M146.19M96.87M112k-77.19M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -31.18M-63.36M-90.57M-118.11M-29.35M
      Investing 29.51M68.64M107.07M144.45M27.1M
      Financing 102k205k1.59M1.78M1.17M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -46.34M-31.29M-50.25M193.61M-118.11M
      Investing -964k-108.91M36.17M-244.32M144.45M
      Financing 23.97M217.47M22.42M1.76M1.78M

      Stats and Ratios

      Market Cap 287.88M
      Price to Earnings Ratio -2.92
      Price to Sales Ratio 8.43
      Price to Cash Ratio 3.58
      Price to Book Ratio -3.73
      Dividend Yield -

      Share Statistics

      Shares Outstanding 42.59M
      Average Volume (1 week) 63.85k
      Average Volume (1 Month) 139.59k
      52 Week Change -12.89%
      52 Week High 9.97
      52 Week Low 2.70
      Spread (Intraday) 6.35 (60.48%)

      Company Info

      Company Name Foghorn Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.foghorntx.com
      Industry pharmaceutical preparations (2834)